LOADING
Comparing AbbVie Inc (ABBV) and Nike Inc (NKE) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | NKE |
|---|---|---|
| Price | $263.30 | $43.22 |
| Change Today | +0.04% | +0.39% |
| Market Cap | $465.0B | $63.9B |
| P/E Ratio | 126.5 | 20.1 |
| Forward P/E | 18.2 | 24.2 |
| PEG Ratio | 0.42 | 1.61 |
| EPS | $2.08 | $2.14 |
| Revenue Growth (YoY) | 12.4% | -1.1% |
| Profit Margin | 5.8% | 6.7% |
| Return on Equity | 62.3% | 22.1% |
| Dividend Yield | 2.62% | 3.87% |
| Beta | 0.28 | 1.13 |
| 52-Week High | $266.92 | $78.01 |
| 52-Week Low | $181.97 | $40.00 |
| Volume | 5.6M | 15.0M |
AbbVie Inc is the larger company by market capitalization. Nike Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Nike Inc offers a higher dividend yield for income investors. Nike Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.